15.05.2025 New collaboration | Ecraid and VAC4EU join forces Strengthening vaccine research and monitoring risks and benefits
30.04.2025 ECRAID-Prime expands trial with new antiviral treatment New LTX-109 intranasal spray will be added to ongoing adaptive platform trial in primary care.
29.04.2025 Science & Knowledge Sharing at ESCMID Global 2025 Looking back on Ecraid's 4th time at ESCMID Global in Vienna.
28.04.2025 Postgraduate Course 2025: Better Methods for Clinical Studies The course takes place on 28-30 October 2025 in Athens, Greece.
21.04.2025 20,000 Patients in ECRAID-Base POS This milestone reflects the collaboration, commitment, and hard work of everyone involved.
14.04.2025 Marion Koopmans receives the ESCMID Award for Outstanding Contributions in the Field of Infection
